B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature.

Autor: Arribas, I.¹ (AUTHOR), Maluquer, C.¹ (AUTHOR), Pomares, H.¹ (AUTHOR), Carro, I.¹ (AUTHOR), Baca, C.¹ (AUTHOR), Bosch, A.¹ (AUTHOR), Arévalo, C. E.¹ (AUTHOR), Montané, C.¹ (AUTHOR), Ribes-Amorós, J.¹ (AUTHOR), Zamora, L.² (AUTHOR), Granada, I.² (AUTHOR), Gamundi, E.³ (AUTHOR), Arnan, M.¹ (AUTHOR), Sureda, A.¹ (AUTHOR)

Publikováno v: Leukemia & Lymphoma. Oct2023, Vol. 64 Issue 10, p1701-1705. 5p.

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study

Autor: Pinato, DJ, Aguilar-Company, J, Ferrante, D, Hanbury, G, Bower, M, Salazar, R, Mirallas, O, Sureda, A, Plaja, A, Cucurull, M, Mesia, R, Townsend, S, Jackson, A, Dalla Pria, A, Newsom-Davis, T, Handford, J, Sita-Lumsden, A, Apthorp, E, Vincenzi, B, Bertuzzi, A, Brunet, J, Lambertini, M, Maluquer, C, Pedrazzoli, P, Biello, F, Sinclair, A, Bawany, S, Khalique, S, Rossi, S, Rogers, L, Murphy, C, Belessiotis, K, Carmona-Garcia, MC, Sharkey, R, Garcia-Illescas, D, Rizzo, G, Perachino, M, Saoudi-Gonzalez, N, Doonga, K, Fox, L, Roldan, E, Gaidano, G, Ruiz-Camps, I, Bruna, R, Patriarca, A, Martinez-Vila, C, Cantini, L, Zambelli, A, Giusti, R, Mazzoni, F, Caliman, E, Santoro, A, Grosso, F, Parisi, A, Queirolo, P, Aujayeb, A, Rimassa, L, Prat, A, Tucci, M, Libertini, M, Grisanti, S, Mukherjee, U, Diamantis, N, Fusco, V, Generali, D, Provenzano, S, Gennari, A, Tabernero, J, Cortellini, A

Publikováno v: LANCET ONCOLOGY
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Background The omicron (B.1.1.529) variant of SARS-CoV-2 is highly transmissible and escapes vaccine-induced immunity. We aimed to describe outcomes due to COVID-19 during the omicron outbreak compared with the prevaccination period and alpha (B.1.1.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::4a67786bb4e1096fb306c45ffab05396
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7192

P40 - Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: BETTER THERAPEUTIC APPROACH AFTER COMPREHENSIVE GERIATRIC ASSESSMENT IN OLDER PATIENTS WITH MYELODYSPLASTIC SYNDROME.

Autor: Blazevic, D., Pomares, H., Boqué, C., Galiano, M., Villarreal, J., Maluquer, C., Sureda, A., Arnan, M., Antonio, M.

Publikováno v: In Leukemia Research September 2021 108 Supplement

Metachronous Marginal Zone Lymphoma Followed by a Peripheral T-Cell Lymphoma in the Same Patient. Report of Two Cases and Review of the Literatures

Autor: Maluquer C, Condom M, Varela M, Climent F, Domingo Domenech E, Sureda A, Gonzalez Barca E

Publikováno v: Austin Hematology. 6

Marginal Zone Lymphomas (MZL) and Peripheral T Cell Lymphomas (PTCL) are uncommon neoplasms and patients affected by both lymphomas in a lifetime have been rarely reported. Here we present two patients with an initial diagnosis of a MZL who further d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dfd0d8c88e2e6934a01b87039bccc4cf
https://doi.org/10.26420/austinhematol.2021.1031

Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials

Autor: Ribera J, Morgades M, Genesca E, Chapchap E, Montesinos P, Acuna-Cruz E, Gil C, Garcia-Cadenas I, Barba P, Gonzalez-Campos J, de Llano M, Torrent A, Granada I, Bernal T, Diaz-Beya M, Amigo M, Coll R, Tormo M, Vall-llovera F, Gomez-Centurion I, Sanchez-Sanchez M, Soria B, Cladera A, Artola M, Garcia-Guinon A, Gimenez-Conca A, Amador M, Martinez-Sanchez P, Algarra J, Vidal M, Alonso N, Maluquer C, Llorente L, Garcia-Boyero R, Ciudad J, Feliu E, Orfao A, PETHEMA Grp

Publikováno v: HEMATOLOGICAL ONCOLOGY
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
Digital.CSIC. Repositorio Institucional del CSIC
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
r-FISABIO. Repositorio Institucional de Producción Científica
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Hematological Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe

Despite high complete remission (CR) rates with frontline therapy, relapses are frequent in adults with T-cell acute lymphoblastic leukemia (T-ALL) with limited salvage options. We analyzed the outcomes and prognostic factors for CR to salvage therap

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b053bd63253cbbe04e08bbc52aafaf9
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=7650